Associated Papers
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I et al.
Journal of Translational Medicine, 2024
38750555 (PubMed )
Supplement: 12967_2024_5227_MOESM15_ESM.xlsx › S15
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.
Calender A et al.
Bmc Medical Genomics, 2018
29510755 (PubMed )
Supplement: 12920_2018_338_MOESM6_ESM.xlsx › T2
Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach.
Karageorgos I et al.
Human Genomics, 2015
26092435 (PubMed )
Supplement: 40246_2015_34_MOESM1_ESM.xlsx › FamilyA
AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non-carriers.
Zhang Y et al.
Molecular Biology Reports, 2012
Investigation of the 1758G>C and 2880A>G variants within the NCOA3 gene in a breast cancer affected Australian population.
Gabrovska PN et al.
Gene, 2011
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.
Zhang B et al.
The Lancet. Oncology, 2011
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.
Hartmaier RJ et al.
Bmc Cancer, 2009
20003447 (PubMed )
Supplement: 1471-2407-9-438-S1.XLSX › SRC-3
Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
Haiman CA et al.
Bmc Cancer, 2009
The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.
Colilla S et al.
Carcinogenesis, 2006
Association of NCOA3 polymorphisms with breast cancer risk.
Burwinkel B et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2005
Select a paper to view details